Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1476-5594
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer ; volume:38 ; number:10 ; day:23 ; month:10 ; year:2018 ; pages:1717-1733 ; date:3.2019
Oncogene ; 38, Heft 10 (23.10.2018), 1717-1733, 3.2019

Urheber
Wagner, Steve
Vlachogiannis, Georgios
Haven Brandon, Alexis De
Valenti, Melanie
Box, Gary
Jenkins, Liam
Mancusi, Caterina
Self, Annette
Manodoro, Floriana
Assiotis, Ioannis
Robinson, Penny
Chauhan, Ritika
Rust, Alistair G.
Matthews, Nik
Eason, Kate
Khan, Khurum
Starling, Naureen
Cunningham, David
Sadanandam, Anguraj
Isacke, Clare M.
Kirkin, Vladimir
Valeri, Nicola
Whittaker, Steven R.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41388-018-0554-z
URN
urn:nbn:de:101:1-2019110502335033783680
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:19 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Wagner, Steve
  • Vlachogiannis, Georgios
  • Haven Brandon, Alexis De
  • Valenti, Melanie
  • Box, Gary
  • Jenkins, Liam
  • Mancusi, Caterina
  • Self, Annette
  • Manodoro, Floriana
  • Assiotis, Ioannis
  • Robinson, Penny
  • Chauhan, Ritika
  • Rust, Alistair G.
  • Matthews, Nik
  • Eason, Kate
  • Khan, Khurum
  • Starling, Naureen
  • Cunningham, David
  • Sadanandam, Anguraj
  • Isacke, Clare M.
  • Kirkin, Vladimir
  • Valeri, Nicola
  • Whittaker, Steven R.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage

Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damage

MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells

MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancers

Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancers

Target Mutant KRAS with Molecular Glue

Target Mutant KRAS with Molecular Glue

A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS

A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

A pan-KRAS degrader for the treatment of KRAS-mutant cancers

A pan-KRAS degrader for the treatment of KRAS-mutant cancers

Current therapy of KRAS-mutant lung cancer

Current therapy of KRAS-mutant lung cancer

RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade

RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression

Charakterisierung der Phosphatase PTPRO als MEK-Inhibitor-Primärresistenzmechanismus im KRAS-mutierten Kolonkarzinom

Hochschulschrift

Charakterisierung der Phosphatase PTPRO als MEK-Inhibitor-Primärresistenzmechanismus im KRAS-mutierten Kolonkarzinom

Verbundene Objekte